Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes
- 27 October 2009
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 127 (2) , 163-182
Abstract
Nitric oxide (NO) mediates host resistance to severe malaria and other infectious diseases. NO production and mononuclear cell expression of the NO producing enzyme-inducible nitric oxide synthase (NOS2) have been associated with protection from severe falciparum malaria. The purpose of this study was to identify single nucleotide polymorphisms (SNPs) and haplotypes in the NOS2 promoter, to identify associations of these haplotypes with malaria severity and to test the effects of these polymorphisms on promoter activity. We identified 34 SNPs in the proximal 7.3 kb region of the NOS2 promoter and inferred NOS2 promoter haplotypes based on genotyping 24 of these SNPs in a population of Tanzanian children with and without cerebral malaria. We identified 71 haplotypes; 24 of these haplotypes comprised 82% of the alleles. We determined whether NOS2 promoter haplotypes were associated with malaria severity in two groups of subjects from Dar es Salaam (N = 185 and N = 250) and in an inception cohort of children from Muheza-Tanga, Tanzania (N = 883). We did not find consistent associations of NOS2 promoter haplotypes with malaria severity or malarial anemia, although interpretation of these results was potentially limited by the sample size of each group. Furthermore, cytokine-induced NOS2 promoter activity determined using luciferase reporter constructs containing the proximal 7.3 kb region of the NOS2 promoter and the G-954C or C-1173T SNPs did not differ from NOS2 promoter constructs that lacked these polymorphisms. Taken together, these studies suggest that the relationship between NOS2 promoter polymorphisms and malaria severity is more complex than previously described.Keywords
This publication has 72 references indexed in Scilit:
- Cellular Tumor Necrosis Factor, Gamma Interferon, and Interleukin-6 Responses as Correlates of Immunity and Risk of Clinical Plasmodium falciparum Malaria in Children from Papua New GuineaInfection and Immunity, 2009
- Genome-wide and fine-resolution association analysis of malaria in West AfricaNature Genetics, 2009
- Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malariaProceedings of the National Academy of Sciences, 2008
- Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malariaCurrent Opinion in Infectious Diseases, 2008
- Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malariaJournal of Experimental Medicine, 2007
- Maternal Malaria and Gravidity Interact to Modify Infant Susceptibility to MalariaPLOS Medicine, 2005
- Analysis of polymorphic sites in the promoter of the nitric oxide synthase 2 geneBiochemical and Biophysical Research Communications, 2005
- BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequencesFEMS Microbiology Letters, 1999
- Promoter Analysis of Human Inducible Nitric Oxide Synthase Gene Associated with Cardiovascular HomeostasisBiochemical and Biophysical Research Communications, 1994
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986